Krishna Institute of Medical Sciences

686.05
+12.30
(1.83%)
Market Cap
27,451.50 Cr
EPS
9.61
PE Ratio
72.89
Dividend Yield
0.00 %
52 Week High
708.00
52 Week Low
412.00
PB Ratio
12.84
Debt to Equity
0.58
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+88.89 %
+88.89 %
Hold
Hold+11.11 %
+11.11 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,298.20
#1 1,26,204.10
111.47
7,028.46
18.77
1,070
26.84
66.67
7,553.50
1,08,607.70
75.12
#1 21,794.00
14.74
1,513
60.41
70.65
807.05
60,928.90
71.95
7,782.75
8.99
809
-7.43
67.42
2,011.40
41,105.10
#1 51.59
5,482.98
10.96
807
3.41
55.67
633.15
32,804.80
88.45
4,138.46
22.85
#1 5,417
#1 3,986.36
66.33
1,183.80
31,795.40
61.28
3,692.32
#1 25.09
486
-20.35
52.92
686.05
#7 27,451.50
#6 72.89
#7 3,035.10
#8 12.94
#7 409
#3 48.39
57.58
1,599.40
16,242.20
68.30
1,566.90
17.46
244
10.57
66.99
1,506.50
9,877.50
52.43
1,290.20
17.77
194
-0.88
55.50
566.30
7,895.10
177.55
2,218.14
12.97
28
-71.06
58.80
Forecast
Actual
Growth Rate
Revenue Growth
12.94 %
Net Income Growth
-8.15 %
Cash Flow Change
20.60 %
ROE
-14.99 %
ROCE
-23.55 %
EBITDA Margin (Avg.)
-8.15 %

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
958
1,118
1,196
1,436
1,907
2,941
3,852
5,736
Fixed Assets
755
863
916
931
1,005
1,766
2,434
4,224
Current Assets
156
174
220
451
393
478
547
697
Capital Work in Progress
0
0
2
9
21
477
600
1,214
Investments
0
0
0
0
333
68
157
64
Other Assets
203
254
278
496
549
630
661
0
Total Liabilities
958
1,118
1,196
1,436
1,907
2,941
3,852
5,736
Current Liabilities
749
201
219
278
215
297
452
836
Non Current Liabilities
347
351
366
282
282
707
1,307
2,481
Total Equity
-138
566
611
876
1,411
1,938
2,093
2,138
Reserve & Surplus
-209
466
523
786
1,307
1,590
1,748
2,058
Share Capital
50
75
75
78
80
80
80
80

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
5
-11
5
3
-3
33
12
-27
36
-15
Investing Activities
-71
-41
-100
-64
-110
-125
-354
-412
-416
-753
Operating Activities
64
95
82
106
134
202
356
324
432
521
Financing Activities
12
-66
24
-39
-27
-44
10
61
20
217

Share Holding

% Holding
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.82 %
38.82 %
38.82 %
38.82 %
38.82 %
38.82 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.61 %
8.61 %
0.00 %
14.25 %
0.00 %
16.73 %
17.84 %
15.85 %
15.68 %
15.45 %
DIIs
13.81 %
16.11 %
18.35 %
18.49 %
20.46 %
27.98 %
28.32 %
29.76 %
33.03 %
34.80 %
31.63 %
33.13 %
32.12 %
32.30 %
32.05 %
31.95 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.14 %
14.23 %
13.38 %
12.88 %
11.81 %
11.50 %
11.32 %
11.10 %
11.22 %
11.15 %
10.84 %
10.73 %
10.61 %
10.55 %
10.97 %
11.24 %
Others
34.21 %
30.82 %
29.42 %
29.79 %
28.88 %
21.68 %
12.92 %
11.69 %
16.91 %
0.96 %
18.70 %
0.59 %
0.61 %
2.48 %
2.48 %
2.54 %
No of Share Holders
0
267
86,389
74,355
73,664
70,795
67,735
60,980
65,449
66,957
71,014
69,092
69,063
77,617
95,468
1,01,895

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2025 651.55 685.85
12 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2025 658.95 651.55
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 592.95 654.10
09 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Nov 2024 522.75 570.15
28 Jun 2024 SPLIT Split
2:10
13 Sept 2024 416.87 416.87
29 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2024 385.70 492.77

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 23, 2025
Closure of Trading WindowJun 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Allotment Of Equity Shares By KIMS Hospital Bengaluru Private Limited A Wholly-Owned Subsidiary Of The Company On Preferential Basis.Jun 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 12, 2025
Re-Appointment Of Mrs. Y. Prameela Rani As An Independent Director For The Further Period Of 5 Years W.E.F 19.05.2025.May 12, 2025
Appointment Of Secretarial Auditors And Appointment Of Cost Auditors.May 12, 2025
Results-Financial Result For The Quarter And Year Ended 31.03.2025May 12, 2025
Board Meeting Outcome for Outcome Of Board MeetingMay 12, 2025
Board Meeting Intimation for KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED Has Informed The Exchange About Board Meeting To Be Held On 12-May-2025 To Inter-Alia Consider And Approve The Audited Financial Results Of The Company For The Yearly Ended March 2May 02, 2025
KIMS : Krishna Institute Of Medical Sciences Limited Has Informed Regarding Receipt Of Approval Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 28, 2025
Closure of Trading WindowMar 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 19, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2025
Krishna Institute Of Medical Sciences Limited Has Informed The Exchange About Intimation Of The Order Received From The Regional Director (South-East Region) Confirming The Scheme Of Amalgamation U/S 233 Of Companies Act 2013 For The Merger Of RajyalakshmMar 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 22, 2025
KIMS Entered Into An Operations And Management Agreement With Splendid Hospitals Private Limited Hyderabad Telangana.Feb 20, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 17, 2025
KIMS Entered Into An Operations And Management Agreement With Ushahkal Abhinav Institute Of Medical Sciences (UAIMS Hospital) Sangli Maharashtra.Feb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 06, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2025
Integrated Filing (Financial)Feb 06, 2025
Quarterly Result_31St December 2024Feb 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 06â„¢ February 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 31, 2025
KIMS Swastha Private Limited (The KIMS) A Wholly-Owned Subsidiary Of Krishna Institute Of Medical Sciences Limited Has Entered Into An Agreement On 27Th January 2025 With Valiyath Institute Of MedicalJan 28, 2025
Board Meeting Intimation for The Approval Of The Unaudited (Standalone & Consolidated) Financial Results Of The Company For The 03Rd Quarter And Nine Months Ended December 31 2024Jan 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 07, 2025

Technical Indicators

RSI(14)
Neutral
57.58
ATR(14)
Volatile
22.46
STOCH(9,6)
Overbought
81.20
STOCH RSI(14)
Overbought
82.90
MACD(12,26)
Bullish
2.95
ADX(14)
Weak Trend
12.57
UO(9)
Bearish
53.37
ROC(12)
Uptrend And Accelerating
3.15
WillR(14)
Overbought
-16.68

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
SBI Multicap Fund Direct - Growth
2.16%
-900000
-0.26%
-0.31%
Invesco India Large & Mid Cap Fund Direct-Growth
0.73%
779983
0.73%
0.73%
Invesco India Smallcap Fund Direct - Growth
3.41%
627113
0.48%
0.60%
Nippon India Pharma Fund Direct-Growth
0.00%
-461785
-0.37%
-0.37%
ICICI Prudential ELSS Tax Saver Direct Plan - Growth
0.06%
-250876
-0.12%
-0.26%
SBI Healthcare Opportunities Fund Direct Plan-Growth
3.34%
-234372
-0.30%
-0.38%
Axis Flexi Cap Fund Direct-Growth
3.35%
231400
0.13%
0.14%
HDFC Hybrid Equity Fund Direct Plan-Growth
1.17%
-200000
-0.03%
-0.03%
Shriram Multi Sector Rotation Fund Direct-Growth
5.06%
68700
2.52%
5.06%
UTI Healthcare Fund Direct-Growth
2.77%
-49650
-0.27%
-0.17%
Nippon India Active Momentum Fund Direct-Growth
0.00%
-45507
-1.99%
-2.22%
TRUSTMF Small Cap Fund Direct-Growth
0.95%
-41532
-0.41%
-0.43%
Bandhan Small Cap Fund Direct-Growth
0.26%
-38113
-0.05%
-0.13%
ITI Bharat Consumption Fund Direct-Growth
0.00%
-34780
-1.25%
-0.78%
Mirae Asset Small Cap Fund Direct-Growth
2.08%
31528
-0.05%
-0.05%
Axis ELSS Tax Saver Direct Plan-Growth
0.38%
30213
0.02%
0.02%
Kotak Quant Fund Direct - Growth
1.98%
-26001
-0.08%
-0.22%
Union Aggressive Hybrid Fund Direct - Growth
1.05%
20000
0.22%
0.22%
Invesco India Business Cycle Fund Direct-Growth
4.07%
18187
-0.09%
-0.47%
Shriram Flexi Cap Fund Direct - Growth
1.01%
-12100
-0.55%
1.01%
WhiteOak Capital Quality Equity Fund Direct-Growth
0.91%
7029
0.03%
0.11%
Shriram ELSS Tax Saver Fund Direct - Growth
0.72%
-6600
-0.88%
0.72%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.88%
5850
-0.05%
-0.04%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
3.89%
4863
0.12%
0.04%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.88%
3506
-0.05%
-0.04%

About Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences Limited (KIMS) is an Indian healthcare company operating 12 multispecialty hospitals under the KIMS Hospitals brand. With over 4,000 beds, KIMS provides tertiary and quaternary healthcare services across more than 40 specialties and super specialties. The company's network includes hospitals in Telangana, Andhra Pradesh, and Maharashtra. KIMS offers medical education programs through affiliations with state medical boards and universities. The company's hospitals are equipped with advanced medical technology, including robotic surgical systems and specialized imaging equipment. KIMS has received various accreditations and awards for its healthcare services and facilities. In recent developments, Sunshine Hospitals became a subsidiary of KIMS in 2022, and the company opened a new gastroenterology unit in Vizag.
Listing Date
28 Jun, 2021(4 Years, -22 days)
Chairperson NameBhaskara Rao Bollineni